Form 8-K - Current report:
SEC Accession No. 0001628280-25-031311
Filing Date
2025-06-13
Accepted
2025-06-13 16:10:00
Documents
18
Period of Report
2025-06-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K intensity-20250611.htm   iXBRL 8-K 40968
2 EX-1.1 & 4.1 exhibit11-8xkjune2025.htm EX-1.1 512323
3 EX-5.1 & 23.1 exhibit51-8xkjune2025.htm EX-5.1 13470
4 EX-99.1 exhibit991-8xkjune2025.htm EX-99.1 15074
5 EX-99.2 exhibit992-8xkjune2025.htm EX-99.2 14897
9 intensitylogo.jpg GRAPHIC 17064
10 mintzlogo.jpg GRAPHIC 4565
  Complete submission text file 0001628280-25-031311.txt   869146

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT intensity-20250611.xsd EX-101.SCH 1827
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT intensity-20250611_lab.xml EX-101.LAB 23449
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT intensity-20250611_pre.xml EX-101.PRE 13606
20 EXTRACTED XBRL INSTANCE DOCUMENT intensity-20250611_htm.xml XML 2935
Mailing Address 1 ENTERPRISE DRIVE, SUITE 430 SHELTON CT 06484
Business Address 1 ENTERPRISE DRIVE, SUITE 430 SHELTON CT 06484 203-221-7381
INTENSITY THERAPEUTICS, INC. (Filer) CIK: 0001567264 (see all company filings)

EIN.: 461488089 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41109 | Film No.: 251046615
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)